相似文献
1
History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.
Gastroenterology. 2010 Mar;138(3):854-69. doi: 10.1053/j.gastro.2010.01.002. Epub 2010 Jan 18.
2
Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management.
J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:11-30. doi: 10.1111/j.1440-1746.2010.06535.x.
3
[Barrett's esophagus: diagnosis and therapy].
Praxis (Bern 1994). 2005 May 25;94(21):861-8. doi: 10.1024/0369-8394.94.21.861.
4
Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.
Endoscopy. 2008 Dec;40(12):994-9. doi: 10.1055/s-2008-1077785. Epub 2008 Dec 8.
5
A Practical Approach to Refractory and Recurrent Barrett's Esophagus.
Gastrointest Endosc Clin N Am. 2021 Jan;31(1):183-203. doi: 10.1016/j.giec.2020.09.002.
6
Endoscopic follow-up and management of Barrett's esophagus in relation to its preneoplastic potential.
Hepatogastroenterology. 2014 Jul-Aug;61(133):1241-5.
7
Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Gastroenterology. 2016 Nov;151(5):822-835. doi: 10.1053/j.gastro.2016.09.040. Epub 2016 Oct 1.
8
Barrett's esophagus.
Gastrointest Endosc Clin N Am. 1994 Oct;4(4):773-89.
9
Gastroesophageal reflux disease: From heartburn to cancer.
World J Gastroenterol. 2010 Aug 14;16(30):3743-4. doi: 10.3748/wjg.v16.i30.3743.
10
Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
Gastroenterol Clin North Am. 2015 Jun;44(2):299-315. doi: 10.1016/j.gtc.2015.02.005. Epub 2015 Mar 31.
引用本文的文献
1
Translating Molecular Biology Discoveries to Develop Targeted Cancer Interception in Barrett's Esophagus.
Int J Mol Sci. 2023 Jul 11;24(14):11318. doi: 10.3390/ijms241411318.
2
Esophageal secondary peristalsis following acid infusion and chemical clearance correlate with mucosal integrity and acid sensitivity in GERD patients.
Therap Adv Gastroenterol. 2023 Jun 29;16:17562848231179329. doi: 10.1177/17562848231179329. eCollection 2023.
3
Shared features of metaplasia and the development of adenocarcinoma in the stomach and esophagus.
Front Cell Dev Biol. 2023 Mar 13;11:1151790. doi: 10.3389/fcell.2023.1151790. eCollection 2023.
4
Identification of potential biomarkers in Barrett's esophagus derived esophageal adenocarcinoma.
Sci Rep. 2023 Feb 9;13(1):2345. doi: 10.1038/s41598-022-17107-0.
5
RISK OF PRENEOPLASTIC LESIONS IN MUCOSAL PROJECTIONS OF DIFFERENT SIZES OF THE COLUMNAR EPITHELIUM IN THE LOWER ESOPHAGUS.
Arq Bras Cir Dig. 2022 Sep 9;35:e1674. doi: 10.1590/0102-672020220002e1674. eCollection 2022.
6
Alterations in the Ca toolkit in oesophageal adenocarcinoma.
Explor Target Antitumor Ther. 2021;2(6):543-575. doi: 10.37349/etat.2021.00063. Epub 2021 Dec 31.
7
Nitric oxide and inducible nitric oxide synthase levels in EE and NERD patients.
Gastroenterol Hepatol Bed Bench. 2022 Winter;15(1):79-86.
8
Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker.
Oncotarget. 2022 Feb 14;13:347-359. doi: 10.18632/oncotarget.28198. eCollection 2022.
9
Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy.
Nat Rev Gastroenterol Hepatol. 2022 Feb;19(2):95-111. doi: 10.1038/s41575-021-00531-4. Epub 2021 Nov 2.
10
gastroesophageal reflux disease esophageal surgery in bariatrics: a literature review and analysis of the current treatment options.
Ann Transl Med. 2021 May;9(10):899. doi: 10.21037/atm-20-5890.
本文引用的文献
1
In benign Barrett's epithelial cells, acid exposure generates reactive oxygen species that cause DNA double-strand breaks.
Cancer Res. 2009 Dec 1;69(23):9083-9. doi: 10.1158/0008-5472.CAN-09-2518. Epub 2009 Nov 17.
2
Definition of Barrett's esophagus: time for a rethink--is intestinal metaplasia dead?
Am J Gastroenterol. 2009 Oct;104(10):2588-94. doi: 10.1038/ajg.2009.390. Epub 2009 Jul 21.
3
Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus.
Gastroenterology. 2009 Sep;137(3):815-23. doi: 10.1053/j.gastro.2009.05.059. Epub 2009 Jun 12.
4
Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus.
Dis Esophagus. 2010 Jan;23(1):13-9. doi: 10.1111/j.1442-2050.2009.00991.x. Epub 2009 Jun 9.
5
Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia.
Am J Gastroenterol. 2009 Jun;104(6):1366-73. doi: 10.1038/ajg.2009.88. Epub 2009 Apr 21.
6
Radiofrequency ablation in Barrett's esophagus with dysplasia.
N Engl J Med. 2009 May 28;360(22):2277-88. doi: 10.1056/NEJMoa0808145.
7
The Society of Thoracic Surgeons practice guideline series: guidelines for the management of Barrett's esophagus with high-grade dysplasia.
Ann Thorac Surg. 2009 Jun;87(6):1993-2002. doi: 10.1016/j.athoracsur.2009.04.032.
8
Radiofrequency ablation of Barrett's esophagus: should everybody get it?
Gastroenterology. 2009 Jun;136(7):2399-401; discussion 2401-2. doi: 10.1053/j.gastro.2009.04.036. Epub 2009 May 3.
9
Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus.
Am J Surg Pathol. 2009 Jul;33(7):1006-15. doi: 10.1097/PAS.0b013e31819f57e9.
10
Endoscopic therapy for Barrett's esophagus.
Clin Gastroenterol Hepatol. 2009 Jul;7(7):716-20. doi: 10.1016/j.cgh.2009.03.011. Epub 2009 Mar 21.
Zotero 插件